PLERIXAFOR | PLERIXAFOR | ATC L03AX16
IMMUNOMODULATING IMMUNOSTIMULANTS HEMATOPOIETIC STEM CEL1 MOBILIZER CXCR4 CHEMOKINE RECEPTOR INHIBITOR THAT BLOCKS BINDING OF ITS COGNATE LIGAND: STROMAL CELL-DERIVED FACTOR-LALPHA (SDF-1ALPHA) | SUBCUTANEOUS INJECTION | VD 19.5 LITER (65 KILOGRAM) PPB 58 PERCENT Cl 3.3 LITER / HOUR (EQN) HT 4 HOUR (0.24 MILLIGRAM / KILOGRAM) | ALPHA-CHEMOKINE RECEPTOR CXCR4 | C-X-C CHEMOKINE RECEPTOR TYPE 4 PARTIAL AGONIST CHEMBL2107 C-X-C CHEMOKINE RECEPTOR TYPE 4 P61073 C-X-C CHEMOKINE RECEPTOR TYPE 4 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE CHEMOKINE RECEPTOR CXC CHEMOKINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |